Linking Obesity and Depression Through the Gut–Brain Axis: The Impact of Short-Chain Fatty Acids and Inflammation
Authors:
- Vlad Ionuț VlăsceanuVVVlad Ionuț Vlăsceanu
- Sergiu TimofeiovSTSergiu Timofeiov
- Alin Constantin PînzariuAlin Constantin Pînzariu
- Radu Petru SoroceanuRSRadu Petru Soroceanu
- Madalina MaximMMMadalina Maxim
- Lucian AmbrosieLALucian Ambrosie
- Ancuța Andreea MilerAMAncuța Andreea Miler
- Tudor CojocaruTCTudor Cojocaru
- Giulia Mihaela CojocaruGCGiulia Mihaela Cojocaru
- Sebastian Marian LeonteSebastian Marian Leonte
- Alexandra Gabriela TrofinATAlexandra Gabriela Trofin
- Daniel Vasile TimofteDaniel Vasile Timofte
Top Cited Papers
Open Access
Abstract
Obesity is a major public health problem that puts pressure on healthcare systems globally. The purpose of this narrative review is to summarize and analyse recent research on the bidirectional link between obesity and mental health, focusing on the biological, behavioural, dietary, emotional, and metabolic mechanisms arising from gut microbiota interactions. Epidemiological association between obesity and mental health disorders, especially depression and anxiety, often occurs bidirectionally, reinforcing each other. Low-grade systemic inflammation is a condition typically found in obesity, being a fundamental element of neuropsychiatric disorders. Considered the main energy substrate for colon cells, SCFAs are synthesized in the intestine and exert important local effects by reducing both local and systemic inflammation. The intestinal microbiota maintains this homeostasis through the SCFAs it produces. The combined impact of the increased intestinal permeability, immune activation, and disrupted metabolism of SCFAs and tryptophan contributes to the onset and progression of depression and anxiety, as well as to significant cognitive dysfunction, especially in obese individuals. Understanding the mechanisms by which microbiota metabolites influence brain development, neuroplasticity, and behaviour could pave the way for new and innovative therapeutic strategies for the treatment of obesity and depression. Conclusions: The association of these pathologies is not coincidental, as they coexist through overlapping biological pathways that they partially or completely share. The main pathway involved is formed by the brain–gut axis and its mediators (SCFAs).Keywords
This publication has 117 references indexed in Scilit:
- Neuropsychiatric Abnormalities in Metabolic Disturbances: Interplay of Adipokines and NeurotransmissionMolecular Neurobiology, 2025
- Few but Not Futile: A Sparse Nucleus Accumbens Corticotropin-Releasing Factor Population Regulates Reward LearningBiological Psychiatry, 2025
- SES and Bariatric Surgery: The Need for Comprehensive AssessmentObesity Surgery, 2025
- The interplay of gut microbiota, obesity, and depression: insights and interventionsCellular and Molecular Life Sciences, 2024
- Self-Harm Before and Six Months After Obesity SurgeryObesity Surgery, 2024
- Achieving dopamine homeostasis to combat brain-gut functional impairment: behavioral and neurogenetic correlates of reward deficiency syndrome2022
- Perturbations in Gut Microbiota Composition in Psychiatric DisordersJAMA Psychiatry, 2021
- Lipid peroxidation as measured by chromatographic determination of malondialdehyde. Human plasma reference values in health and diseaseArchives of Biochemistry and Biophysics, 2021
- Understanding individual and socio-cultural factors associated with hispanic parents’ provision of sugar-sweetened beverages to young childrenAppetite, 2021
- Overweight, Obesity, and DepressionArchives of General Psychiatry, 2010